Bicara Therapeutics, Inc. (BCAX)
18.20
-0.56
(-2.99%)
USD |
NASDAQ |
Dec 05, 16:00
18.22
+0.02
(+0.14%)
After-Hours: 20:00
Bicara Therapeutics Shareholders Equity (Quarterly): 402.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 92.80B |
| Oncotelic Therapeutics, Inc. | 9.051M |
| Dogwood Therapeutics, Inc. | 77.39M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 424.69M |
| Total Liabilities (Quarterly) | 21.91M |
| Debt to Equity Ratio | 0.0049 |
| Current Ratio | 14.14 |
| Net Debt Paydown Yield | -0.03% |